Menu

Double Duplication

Two whole genome duplications boosted the complexity of the ancestor of all vertebrates, but also introduced potential for disease.

Jul 24, 2012
Hayley Dunning

More than 500 million years ago, the DNA of a primitive chordate sea creature underwent two successive doublings, allowing for the evolution of the complex internal communication between cells that led to the evolution of vertebrates.

Now, researchers have sequenced the genome of the amphioxus, a modern marine invertebrate that did not undergo the genome duplications and is believed to be similar to the original vertebrate ancestor. By comparing the amphioxus genome to the human genome, the study, published today (July 24) in Open Biology, provides insights into how the duplications boosted cells' ability to integrate information, but also reveals how breakdowns in cellular communication cause diseases like cancer, diabetes, and neurological disorders.

“Amazingly, what happened so long ago still affects the life and diseases of modern humans,” said co-author Carol MacKintosh, of the University of Dundee, in a press release. MacKintosh and colleagues are investigating the protein-coding gene duplicates that stem from the two genome doublings to understand their influence on modern humans. "We already have clues about important questions, such as why did only certain genes survive the DNA doublings, how did they shape vertebrate evolution, and what is their impact on human health and diseases?”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.